HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markku Miettinen Selected Research

Keratin-5 (Keratin 5)

9/2012Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.
9/2003Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis.
2/2003Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markku Miettinen Research Topics

Disease

128Neoplasms (Cancer)
03/2024 - 03/2002
28Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2023 - 03/2002
18Carcinoma (Carcinomatosis)
01/2023 - 06/2002
15Mesothelioma
01/2023 - 04/2002
11Melanoma (Melanoma, Malignant)
03/2024 - 04/2002
11Sarcoma (Soft Tissue Sarcoma)
11/2023 - 04/2002
7Paraganglioma (Paragangliomas)
01/2023 - 08/2014
7Malignant Mesothelioma
01/2018 - 09/2012
6Synovial Sarcoma (Synovioma)
10/2023 - 04/2002
6Pheochromocytoma
01/2023 - 04/2016
5Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 01/2017
5Adenocarcinoma
04/2017 - 02/2003
5Leiomyoma (Uterine Fibroids)
12/2016 - 06/2002
4Chordoma
05/2024 - 04/2002
4Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2014
4Neoplasm Metastasis (Metastasis)
01/2021 - 10/2013
4Neurilemmoma (Schwannoma)
03/2016 - 06/2002
3Testicular Neoplasms (Testicular Cancer)
03/2024 - 01/2021
3Stomach Neoplasms (Stomach Cancer)
12/2023 - 01/2023
3Small Cell Carcinoma
10/2015 - 02/2003
3Fibroma (Fibromatosis)
09/2012 - 08/2006
3Clear Cell Sarcoma
05/2012 - 04/2002
3Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
11/2009 - 04/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2003 - 04/2002
2Adrenocortical Carcinoma
12/2023 - 07/2015
2Hereditary leiomyomatosis and renal cell cancer
01/2023 - 12/2016
2Benign Fibrous Histiocytoma (Dermatofibroma)
01/2021 - 09/2012
2Ganglion Cysts (Ganglion)
01/2020 - 09/2012
2Neurofibroma
01/2018 - 03/2003
2Turcot syndrome
10/2017 - 01/2017
2Thymoma (Thymic Carcinoma)
04/2017 - 11/2016
2Carney Triad
04/2016 - 02/2011
2Carney-Stratakis Syndrome
04/2016 - 02/2011
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2015 - 03/2014
2Hemangiopericytoma
05/2015 - 12/2011
2Ewing Sarcoma (Sarcoma, Ewing)
07/2014 - 03/2011
2Glioma (Gliomas)
06/2013 - 01/2006
2Fasciitis (Fascitis)
09/2012 - 03/2003
2Hemangiosarcoma (Angiosarcoma)
12/2011 - 04/2002
2Glomus Tumor (Glomus Tumors)
12/2011 - 03/2002

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
10/2023 - 04/2002
19S100 Proteins (S 100 Protein)IBA
11/2022 - 03/2002
17Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2023 - 02/2011
15Keratins (Keratin)IBA
01/2020 - 06/2002
13DesminIBA
01/2014 - 03/2002
12Monoclonal AntibodiesIBA
04/2023 - 06/2002
11AntigensIBA
03/2024 - 11/2003
11Imatinib Mesylate (Gleevec)FDA Link
01/2019 - 04/2002
9Tyrosine Kinase InhibitorsIBA
09/2019 - 01/2003
8Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2023 - 01/2006
8MesothelinIBA
01/2022 - 02/2003
7DNA (Deoxyribonucleic Acid)IBA
05/2024 - 01/2016
7AntibodiesIBA
10/2023 - 06/2002
6Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2010
6VimentinIBA
07/2020 - 06/2002
6Mucin-1 (CA 15-3 Antigen)IBA
03/2016 - 09/2003
6Glial Fibrillary Acidic ProteinIBA
07/2008 - 06/2002
5CollagenIBA
07/2020 - 08/2005
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 04/2002
5Estrogen ReceptorsIBA
12/2016 - 03/2009
5Transcription Factors (Transcription Factor)IBA
03/2016 - 03/2011
4CateninsIBA
05/2016 - 09/2013
4NucleotidesIBA
02/2015 - 08/2009
4Calbindin 2IBA
09/2012 - 02/2003
4SynaptophysinIBA
06/2012 - 03/2002
3Immune Checkpoint InhibitorsIBA
03/2023 - 01/2016
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2020
3Messenger RNA (mRNA)IBA
11/2022 - 03/2016
3LigandsIBA
01/2021 - 01/2016
3Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2018 - 01/2017
3Mutant Proteins (Protein, Mutant)IBA
01/2018 - 09/2014
3Membrane Proteins (Integral Membrane Proteins)IBA
04/2017 - 11/2011
3Cyclin D1IBA
05/2016 - 02/2015
3Phosphotransferases (Kinase)IBA
03/2016 - 01/2006
3Phenobarbital (Luminal)FDA Link
06/2015 - 02/2008
3Keratin-5 (Keratin 5)IBA
09/2012 - 02/2003
3Neurofilament ProteinsIBA
06/2012 - 09/2003
3MART-1 AntigenIBA
02/2012 - 05/2003
2Brachyury protein (Brachyury)IBA
05/2024 - 10/2015
2Polysaccharides (Glycans)IBA
04/2023 - 03/2023
2Cadherins (E-Cadherin)IBA
01/2023 - 04/2002
2beta CateninIBA
07/2020 - 01/2009
2B7-H1 AntigenIBA
01/2020 - 01/2020
2Anaplastic Lymphoma KinaseIBA
01/2020 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2019 - 11/2014
2Codon (Codons)IBA
01/2018 - 12/2008
2Immunotoxins (Immunotoxin)IBA
03/2017 - 11/2014
2tyrosine receptor (receptor, tyrosine)IBA
03/2016 - 01/2006
2ExotoxinsIBA
07/2015 - 11/2014
2Insulin-Like PeptidesIBA
08/2014 - 01/2013
2CohesinsIBA
07/2014 - 12/2013
2Claudin-5IBA
10/2013 - 12/2011
2NestinIBA
09/2013 - 06/2002
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2013 - 03/2003
2Monophenol Monooxygenase (Tyrosinase)IBA
02/2012 - 05/2003

Therapy/Procedure

29Therapeutics
03/2024 - 04/2002
8Radiotherapy
01/2023 - 02/2008
7Drug Therapy (Chemotherapy)
01/2023 - 02/2008
3Immunotherapy
03/2024 - 05/2019
3Gastrectomy
01/2023 - 01/2021